Director Bozilenko Updates AAPG Equity Holdings Report
ASCENTAGE PHARMA GROUP INTERNATIONAL
Subscribe to track AAPG
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Director Bozilenko Updates AAPG Equity Holdings Report
Company: ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Form: 3/A (Amendment) | Filed: 2026-03-23 Significance: Low
Insider: Bozilenko Marina Title: Director | Relationship: Director
Holdings Reported: • Security: Options & RSUs • Total Derivatives: 45,960 shares (combined) • Option Strike: $8.14
Key Insight: Administrative amendment correcting the number/vesting of previously reported Options and RSUs. Represents <0.02% of outstanding shares.
Market Context: $16.35B Market Cap. Insider holdings are nominal relative to company size.
Comprehensive Analysis
SEC Filing Analysis: ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Director Marina Bozilenko filed an amendment to correct details regarding initial equity holdings (Options and RSUs).
- Market Impact: Neutral. This is an administrative correction, not a new market transaction.
Company Information
| Field | Value |
|---|---|
| Company | ASCENTAGE PHARMA GROUP INTERNATIONAL |
| Ticker Symbol | AAPG |
| CIK | 0002023311 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Bozilenko Marina |
| CIK | 0001853794 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 3/A (Initial Statement Amendment) |
| Report Date | 2026-03-18 |
| Security Type | Options & RSUs |
| Options Reported | 17,965 (Strike $8.14) |
| RSUs Reported | 27,965 |
| Total Holdings | 45,930 (Derivatives) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Market Cap | $16.35 Billion |
| Shares Outstanding | 373,320,000 |
| Holdings Reported | 45,930 |
| % of Shares Outstanding | ~0.012% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: Ascentage is a Large-Cap entity ($16.35B). The holdings reported here are negligible relative to the total capitalization.
- Ownership Concentration: The insider holds approximately 0.012% of the company via derivatives, indicating a minor minority position.
- Dilution Impact: Even if fully exercised/vested, the 45,930 shares represent minimal dilution to existing shareholders.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Form 3/A filings are administrative. This specific filing corrects the number of Share Options and vesting schedules reported in the original submission. It does not reflect new buying or selling pressure.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Correction: Footnote F4 states, "The number of Share Options and/or their vesting were inadvertently incorrectly reported in the original submission."
- Vesting: Options vest monthly starting Nov 2025; RSUs vest annually starting Nov 2026.
- Currency: Option exercise price is converted from HKD to USD ($8.14).
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.